These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 15797934

  • 1. Effects of eplerenone on transcriptional factors and mRNA expression related to cardiac remodelling after myocardial infarction.
    Enomoto S, Yoshiyama M, Omura T, Matsumoto R, Kusuyama T, Kim S, Izumi Y, Akioka K, Iwao H, Takeuchi K, Yoshikawa J.
    Heart; 2005 Dec; 91(12):1595-600. PubMed ID: 15797934
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
    Yoshiyama M, Nakamura Y, Omura T, Izumi Y, Matsumoto R, Oda S, Takeuchi K, Kim S, Iwao H, Yoshikawa J.
    Heart; 2005 Aug; 91(8):1080-5. PubMed ID: 16020603
    [Abstract] [Full Text] [Related]

  • 3. Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction.
    Fraccarollo D, Galuppo P, Hildemann S, Christ M, Ertl G, Bauersachs J.
    J Am Coll Cardiol; 2003 Nov 05; 42(9):1666-73. PubMed ID: 14607457
    [Abstract] [Full Text] [Related]

  • 4. Eplerenone prevents adverse cardiac remodelling induced by pressure overload in atrial natriuretic peptide-null mice.
    Franco V, Chen YF, Feng JA, Li P, Wang D, Hasan E, Oparil S, Perry GJ.
    Clin Exp Pharmacol Physiol; 2006 Sep 05; 33(9):773-9. PubMed ID: 16922805
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
    Takeda M, Tatsumi T, Matsunaga S, Hayashi H, Kimata M, Honsho S, Nishikawa S, Mano A, Shiraishi J, Yamada H, Takahashi T, Matoba S, Kobara M, Matsubara H.
    Hypertens Res; 2007 May 05; 30(5):427-37. PubMed ID: 17587755
    [Abstract] [Full Text] [Related]

  • 7. Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction.
    Fraccarollo D, Galuppo P, Schmidt I, Ertl G, Bauersachs J.
    Cardiovasc Res; 2005 Jul 01; 67(1):97-105. PubMed ID: 15949473
    [Abstract] [Full Text] [Related]

  • 8. Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction.
    Maekawa Y, Anzai T, Yoshikawa T, Sugano Y, Mahara K, Kohno T, Takahashi T, Ogawa S.
    J Am Coll Cardiol; 2004 Oct 06; 44(7):1510-20. PubMed ID: 15464336
    [Abstract] [Full Text] [Related]

  • 9. Critical role of CNS effects of aldosterone in cardiac remodeling post-myocardial infarction in rats.
    Lal A, Veinot JP, Leenen FH.
    Cardiovasc Res; 2004 Dec 01; 64(3):437-47. PubMed ID: 15537497
    [Abstract] [Full Text] [Related]

  • 10. Eplerenone, a selective aldosterone blocker, improves diastolic function in aged rats with small-to-moderate myocardial infarction.
    Masson S, Staszewsky L, Annoni G, Carlo E, Arosio B, Bai A, Calabresi C, Martinoli E, Salio M, Fiordaliso F, Scanziani E, Rudolph AE, Latini R.
    J Card Fail; 2004 Oct 01; 10(5):433-41. PubMed ID: 15470655
    [Abstract] [Full Text] [Related]

  • 11. Effects of eplerenone, a selective aldosterone blocker, on the progression of left ventricular dysfunction and remodeling in rats with dilated cardiomyopathy.
    Wahed MI, Watanabe K, Ma M, Yamaguchi K, Takahashi T, Tachikawa H, Kodama M, Aizawa Y.
    Pharmacology; 2005 Feb 01; 73(2):81-8. PubMed ID: 15467302
    [Abstract] [Full Text] [Related]

  • 12. Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodelling in rats after myocardial infarction.
    Huang BS, White RA, Ahmad M, Tan J, Jeng AY, Leenen FH.
    Cardiovasc Res; 2009 Feb 15; 81(3):574-81. PubMed ID: 18689429
    [Abstract] [Full Text] [Related]

  • 13. Carvedilol may alleviate late cardiac remodelling following surgical ventricular restoration.
    Yoshikawa E, Marui A, Tsukashita M, Nishina T, Wang J, Muranaka H, Ikeda T, Komeda M.
    Eur J Cardiothorac Surg; 2010 Feb 15; 37(2):362-7. PubMed ID: 19692266
    [Abstract] [Full Text] [Related]

  • 14. Left ventricular remodeling after acute myocardial infarction: does eplerenone have an effect?
    Weir RA, Mark PB, Petrie CJ, Clements S, Steedman T, Ford I, Ng LL, Squire IB, Wagner GS, McMurray JJ, Dargie HJ.
    Am Heart J; 2009 Jun 15; 157(6):1088-96. PubMed ID: 19464421
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prevention of cardiac remodeling after myocardial infarction in transgenic rats deficient in brain angiotensinogen.
    Lal A, Veinot JP, Ganten D, Leenen FH.
    J Mol Cell Cardiol; 2005 Sep 15; 39(3):521-9. PubMed ID: 15950985
    [Abstract] [Full Text] [Related]

  • 17. [Effects of perindopril on left ventricular remodeling and myocardial osteopontin expression in rats with myocardial infarction].
    Zhang YL, Zhou SX, Wang MH, Wang JF.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov 15; 26(11):1584-8. PubMed ID: 17121705
    [Abstract] [Full Text] [Related]

  • 18. Spironolactone alleviates late cardiac remodeling after left ventricular restoration surgery.
    Tsukashita M, Marui A, Nishina T, Yoshikawa E, Kanemitsu H, Wang J, Ikeda T, Komeda M.
    J Thorac Cardiovasc Surg; 2008 Jul 15; 136(1):58-64. PubMed ID: 18603054
    [Abstract] [Full Text] [Related]

  • 19. Nipradilol can prevent left ventricular systolic and diastolic dysfunction after myocardial infarction in rats.
    Izutani S, Yoshiyama M, Omura T, Yoshida K, Nakamura Y, Kim S, Takeuchi K, Yoshikawa J.
    Circ J; 2002 Mar 15; 66(3):289-93. PubMed ID: 11922280
    [Abstract] [Full Text] [Related]

  • 20. Effects of aldosterone receptor antagonist and angiotensin II type I receptor blocker on cardiac transcriptional factors and mRNA expression in rats with myocardial infarction.
    Matsumoto R, Yoshiyama M, Omura T, Kim S, Nakamura Y, Izumi Y, Akioka K, Iwao H, Takeuchi K, Yoshikawa J.
    Circ J; 2004 Apr 15; 68(4):376-82. PubMed ID: 15056838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.